New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19
06/05/2021 08:00 AM
BEIJING, May 6, 2021 /PRNewswire/ Recently, new progress has been made in the study of the pharmacologically active ingredients and mechanism of Chinese medicine Lianhua Qingwen Capsules in the prevention and treatment of COVID-19. Lianhua Qingwen Capsules is an innovative Chinese medicine developed by Yiling Pharmaceutical, which is mainly used for the treatment of cold, flu and other diseases. Since the outbreak of COVID-19, Lianhua Qingwen Capsules have been recommended by the official Chinese “Diagnosis and Treatment Protocol for COVID-19” and widely used in designated admission hospitals for COVID-19. Currently, the drug has been approved for marketing in 23 countries and regions, including Canada, Russia, Cambodia and Indonesia.
Press release content from Business Wire. The AP news staff was not involved in its creation.
New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19
February 26, 2021 GMT
SHIJIAZHUANG, China (BUSINESS WIRE) Feb 26, 2021
Recently, Prof. Caisheng Wu and Prof. Yifeng Chai from the School of Pharmacy, Xiamen University have made new progress in the study of the pharmacologically active ingredients and mechanism of Lianhua Qingwen Capsules in the prevention and treatment of COVID-19. The study result, “Screening of the Anti-COVID-19 Pharmacological Active Ingredients of Traditional Chinese Medicine Lianhua Qingwen Capsules Based on Human Exposure and ACE2 Biochromatography”, was published in the top journal of pharmacology,
New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19
SHIJIAZHUANG, China, Feb. 23, 2021 /PRNewswire/ Recently, Prof. Caisheng Wu and Prof. Yifeng Chai from the School of Pharmacy, Xiamen University have made new progress in the study of the pharmacologically active ingredients and mechanism of Lianhua Qingwen Capsules, developed and produced by Yiling Pharmaceutical, in the prevention and treatment of COVID-19. The study result, Screening of the Anti-COVID-19 Pharmacological Active Ingredients of Traditional Chinese Medicine Lianhua Qingwen Capsules Based on Human Exposure and ACE2 Biochromatography , was published in the top journal of pharmacology,
Acta Pharmaceutica Sinica B. This is the latest evidence of the prevention and treatment of COVID-19 by the Chinese medicine Lianhua Qingwen.